Halozyme Therapeutics Inc $9.23

down -0.06


24/7/2014 09:49 AM  |  NASDAQ : HALO  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get HALO Trend Analysis - it has underperformed the S&P 500 by 6%

Partner Headlines

  1. Halozyme Announces Resumption of Patient Enrollment, Dosing in PEGPH20 ...

    Benzinga
  2. Benzinga's Top Initiations

    Benzinga
  3. JP Morgan Initiates Halozyme Therapeutics With Outperform

    Benzinga
  4. Benzinga's Top #PreMarket Gainers

    Benzinga
  5. Mid-Day Market Update: US Stocks Surge; PVH Shares Slip On Downbeat Results

    Benzinga
  6. Shares Of Halozyme Up 14% Following FDA Removal Of Hold On PEGPH20

    Benzinga
  7. Morning Market Movers

    Benzinga
  8. Benzinga's Top #PreMarket Gainers

    Benzinga
  9. Mid-Afternoon Market Update: Markets Trade In Choppy Session As Elizabeth ...

    Benzinga
  10. Mid-Day Movers: GORO, HALO, COCO, UEC, EVDY Moving Higher; RDEN, CALL, ...

    Benzinga
  11. Mid-Day Market Update: Rackspace Gains On Upbeat Earnings; DXP Enterprises ...

    Benzinga
  12. Mid-Morning Market Update: Markets Gain; Elizabeth Arden To Explore Strategic ...

    Benzinga
  13. Morning Market Movers

    Benzinga
  14. Benzinga's Top #PreMarket Gainers

    Benzinga
  15. Mid-Morning Market Update: Markets Gain; Johnson & Johnson Profit Beats ...

    Benzinga
  16. Morning Market Movers

    Benzinga
  17. Benzinga's Top #PreMarket Gainers

    Benzinga
  18. Benzinga's Top Initiations

    Benzinga
  19. Markets Falling? Get Your Defense Ready

    Benzinga
  20. Morning Market Losers

    Benzinga
  21. Benzinga's Top #PreMarket Losers

    Benzinga
  22. UPDATE: Halozyme Reports Clinical Hold of PEGPH20 Pancreatic Cancer Trial ...

    Benzinga
  23. Biotechs Struggling To Find A Bottom

    Benzinga
  24. Halozyme Announces Preclinical Data Presentations At The Association Of ...

    Benzinga
  25. Mid-Afternoon Market Update: Markets Drop, Lead Lower by NASDAQ Momentum ...

    Benzinga
  26. Mid-Day Market Update: NASDAQ Tumbles 1.8%; SYNNEX Shares Gain After Upbeat ...

    Benzinga
  27. Halozyme Shares Plummet as Concerns Halt Trial

    FoxBusiness
  28. Mid-Morning Market Update: Markets Mixed; CarMax Results Miss Estimates

    Benzinga
  29. Benzinga's Top #PreMarket Losers

    Benzinga
  30. UPDATE: Halozyme Announces Temporary Halt of Phase 2 Trial Enrollment

    Benzinga
  31. Mid-Morning Market Update: Markets Open Higher; UTi Worldwide Reports Q4 ...

    Benzinga
  32. Morning Market Movers

    Benzinga
  33. Mid-Afternoon Market Update: Markets Take a Sharp Dip to the Downside, ...

    Benzinga
  34. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE Moving ...

    Benzinga
  35. UPDATE: Halozyme Spikes Higher on Positive CNBC Comments

    Benzinga
  36. Microsoft's First Xbox TV Series Slated For 1H 2014

    Benzinga
  37. Hottest Game Systems For Christmas: PlayStation 4 vs. Xbox One vs. Wii ...

    Benzinga
  38. Halozyme Receives Milestone Payment of $10M from Roche Following Commercial ...

    Benzinga
  39. Coming Soon: Microsoft Cortana vs. Apple Siri (AAPL, MSFT)

    Benzinga
  40. Halozyme Announces Roche Receives Marketing Authorization for Herceptin ...

    Benzinga
  41. Benzinga Market Wrap for Thursday, August 1: Record Highs!

    Benzinga
  42. Mid-Afternoon Market Update: Trulia Rises as Hanger Drops on its Second-Quarter ...

    Benzinga
  43. Mid-Afternoon Market Update: Trulia Rises as Hanger Drops on its Second-Quarter ...

    Benzinga
  44. Mid-Day Market Update: Yelp Surges On Narrower Loss, SunPower Shares Decline

    Benzinga
  45. ViroPharma Kills Halozyme Combo Trial; Stocks Fall

    IBD
  46. Mid-Morning Market Update: Markets Rally, Procter & Gamble Earnings Top ...

    Benzinga
  47. Halozyme Issued Update on ViroPharma Phase 2 Trial of C1 Esterase Inhibitor ...

    Benzinga
  48. Benzinga's Top Pre-Market Losers

    Benzinga
  49. Hollywood Hopes There's Still Money in Video Game-Themed Movies

    Benzinga
  50. UPDATE: BMO Capital Markets Reiterates Outperform Rating, Lowers PT on ...

    Benzinga
Trading Center